Relief For UniQure Hemophilia Program Sends Ball To FTC’s Court

Good News For Gene Therapy Continues As FDA Also Removes Hold On Voyager’s Huntington’s Trial

Hemophilia_525478450_1200.jpg
FDA lifts hold on uniQure's hemophilia B program • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D